Oncology billing and revenue cycle for District of Columbia providers.
District of Columbia operates 34 oncology billing organizations registered in NPPES, representing 0.2 percent of the U.S. oncology billing footprint. District of Columbia is a smaller oncology billing market. Oncology revenue cycle complexity centers on infusion administration code stacking, drug J-code and ASP+6 reimbursement, NCCN-aligned prior authorization, and oncology-specific E/M leveling. District of Columbia oncology practices need RCM partners with deep infusion + drug billing experience.
What good oncology billing execution looks like for District of Columbia providers.
The District of Columbia oncology billing market has its own quirks. Here is the operating discipline we install on every District of Columbia engagement.
- Infusion and chemotherapy administration code accuracyOncology infusion billing requires precise capture of initial, sequential, concurrent, and additional hour codes (96360-96376, 96401-96450, J-codes for drugs). District of Columbia infusion centers leak revenue on undercoded administration time.
- J-code drug pricing and ASP+6 reimbursementOncology drugs reimburse under Medicare at Average Sales Price + 6 percent (Part B), with similar logic on many commercial. District of Columbia oncology practices need accurate J-code billing, NDC reporting, and ASP-aware revenue forecasting.
- Prior authorization for oncology drugsSpecialty oncology drugs require payer prior authorization, often with clinical criteria tied to NCCN guideline alignment. PA automation tuned for oncology compresses access-to-treatment time and reduces denials.
- E/M leveling for oncology visitsOncology visits qualify for higher E/M levels under MDM complexity rules. District of Columbia oncology practices that under-level E/M leave significant revenue uncollected.
- OCM and Enhancing Oncology Model participationPractices in the CMS Enhancing Oncology Model (EOM) coordinate clinical, financial, and reporting workflows for value-based payment. District of Columbia EOM participants need RCM that flows into program reporting.
- 340B drug pricing for eligible oncology entitiesFQHC + DSH-eligible hospital oncology practices in 340B require precise inventory tracking, contract pharmacy coordination, and proper claim modification (TB modifier).
FAQ: oncology billing in District of Columbia.
How many oncology billing providers operate in District of Columbia?
NPPES lists 34 oncology billing organizations in District of Columbia, representing 0.2% of the U.S. footprint. Top concentrations are in Washington (34).
Does DC Medicaid cover oncology billing services?
Yes. DC Medicaid covers oncology billing services for eligible beneficiaries, with plan-specific authorization rules and rate structures that vary by year.
What commercial payers cover oncology billing in District of Columbia?
All major national commercial payers cover oncology billing in District of Columbia, including UnitedHealthcare/Optum, Aetna, Cigna/Evernorth, the dominant District of Columbia Blue Cross Blue Shield plan, and (where active) Humana.
Does ASP-RCM serve oncology billing providers in District of Columbia?
Yes. ASP-RCM Solutions provides oncology billing and revenue cycle services for providers in District of Columbia and across all 50 states. Senior partners on every account. Request a free 30-day audit.
How do I get started?
Request a free 30-day RCM audit. We assess your current state, identify revenue leakage, and produce a written prioritized recommendations list.